I‐Ni Chiang
Papers
1
Total Citations
9
H-Index
1
About
Dr. I‑Ni Chiang is a urologic oncologist whose research focuses on improving risk stratification and surgical outcomes for prostate cancer. Her most cited work investigates the clinical utility of the prostate health index (PHI) and its derivative, %p2PSA, as preoperative biomarkers for predicting aggressive pathology in men undergoing radical prostatectomy. In a 2020 study involving 91 patients with organ‑confined disease, she demonstrated that these markers can help identify those at higher risk for adverse pathological outcomes, potentially guiding treatment decisions and reducing overtreatment. This contribution—garnering nine citations—underscores her commitment to precision medicine in urologic oncology. Dr. Chiang’s broader research portfolio encompasses robot‑assisted surgery, biomarker discovery, and the optimization of perioperative care. Her work bridges the gap between laboratory science and clinical practice, offering tangible tools for risk‑adapted management. As a rising voice in the field, she continues to shape how clinicians evaluate and counsel patients facing prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1